Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicentre Pivotal Clinical Study to Demonstrate the Efficacy and Safety of the VividWhite Glaucoma Implant (VW-51) for the Treatment of Glaucoma.

NCT06176170 is registered in ClinicalTrials.gov with VividWhite Pty Ltd as lead sponsor.

NCT NCT06176170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06176170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicentre Pivotal Clinical Study to Demonstrate the Efficacy and Safety of the VividWhite Glaucoma Implant (VW-51) for the Treatment of Glaucoma.
Lead sponsor
VividWhite Pty Ltd
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 12, 2023
Completion date
December 31, 2026
Enrollment
65 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma